Comparison of three in vitro cytotoxicity assays for estimating surfactant ocular irritation.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 20650078)

Published in Toxicol In Vitro on April 01, 1995

Authors

L Vian1, J Vincent, J Maurin, I Fabre, J Giroux, J P Cano

Author Affiliations

1: Agence du Médicament, 14 rue Ecole de Pharmacie, 34000 Montpellier, France; Laboratoire de Toxicologie, Faculté de Pharmacie, Avenue C. Flahault, 34060 Montpellier cedex, France.

Articles by these authors

Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology (1990) 4.78

A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity (1998) 2.56

Proposal of Afipia gen. nov., with Afipia felis sp. nov. (formerly the cat scratch disease bacillus), Afipia clevelandensis sp. nov. (formerly the Cleveland Clinic Foundation strain), Afipia broomeae sp. nov., and three unnamed genospecies. J Clin Microbiol (1991) 2.44

Remineralization of enamel subsurface lesions by sugar-free chewing gum containing casein phosphopeptide-amorphous calcium phosphate. J Dent Res (2001) 2.03

The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol (1999) 1.93

Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man. Br J Clin Pharmacol (1983) 1.89

Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet (2000) 1.76

[Pharmacokinetics of midazolam after i.v. administration (author's transl)]. Arzneimittelforschung (1981) 1.58

Skin surface retention of an applied ointment. Dermatologica (1974) 1.52

Severe neutropenia caused by recommended prophylactic doses of rifabutin. Lancet (1996) 1.48

Quantification of CD1a, HLA-DR, and HLA class I expression on viable human Langerhans cells and keratinocytes. Cytometry (1996) 1.47

Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab Dispos (1991) 1.43

Septic arthritis due to Kingella (Moraxella) kingii: case report and review of the literature. J Rheumatol (1981) 1.43

Reducing bacteria in dental aerosols: pre-procedural use of an antiseptic mouthrinse. J Am Dent Assoc (1993) 1.43

Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. Drug Metab Dispos (1989) 1.41

Comparative field evaluation of the fluorescent-antibody test, virus isolation from tissue culture, and enzyme immunodiagnosis for rapid laboratory diagnosis of rabies. J Clin Microbiol (1989) 1.40

Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB J (1992) 1.30

Wingless and Hedgehog pattern Drosophila denticle belts by regulating the production of short-range signals. Development (1999) 1.29

Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients. Br J Cancer (2013) 1.26

Rapid catabolism of 5-fluorouracil in freshly isolated rat hepatocytes as analyzed by high performance liquid chromatography. J Biol Chem (1982) 1.25

Near patient testing in diabetes clinics: appraising the costs and outcomes. Health Technol Assess (1999) 1.24

A pragmatic approach to the pressor dose-response as an index of vascular reactivity and adrenoceptor function in man. Br J Clin Pharmacol (1987) 1.22

Bioavailability from various galenic formulations of flunitrazepam. Arzneimittelforschung (1977) 1.19

Dermatoglyphics in pediatric practice. J Pediatr (1966) 1.19

Dermatoglyphics of the broad thumb and great toe syndrome. Am J Dis Child (1967) 1.17

Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases. Atherosclerosis (1990) 1.13

Pharmacokinetics of adriamycin in patients with breast cancer: correlation between pharmacokinetic parameters and clinical short-term response. Eur J Cancer Clin Oncol (1982) 1.09

Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes. Mol Pharmacol (1992) 1.09

Isolated right pulmonary artery discontinuity. Images Paediatr Cardiol (2000) 1.08

Proteases of Antarctic krill--a new system for effective enzymatic debridement of necrotic ulcerations. Experientia (1986) 1.08

Enhancement of 5-fluorouracil cytotoxicity by human thymidine-phosphorylase expression in cancer cells: in vitro and in vivo study. Int J Cancer (1999) 1.06

Increased cytotoxicity and bystander effect of 5-fluorouracil and 5-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase. Br J Cancer (1999) 1.03

Metabolism of cyclosporin A. II. Implication of the macrolide antibiotic inducible cytochrome P-450 3c from rabbit liver microsomes. Drug Metab Dispos (1987) 1.03

Polyglutamylation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro. Cancer Res (1984) 1.03

Efficacy of preprocedural rinsing with an antiseptic in reducing viable bacteria in dental aerosols. J Periodontol (1992) 1.02

Hemizygous deletions on chromosome 1p21.3 involving the DPYD gene in individuals with autism spectrum disorder. Clin Genet (2010) 1.00

[Transmission in water of the germicide energy of ultraviolet rays. Application to the treatment of drinking water]. Bull Acad Natl Med (1970) 0.97

Blood levels of diazepam (Valium) and N-desmethyl diazepam in the epileptic child. A preliminary report. Psychiatr Neurol Neurochir (1972) 0.96

Seroprevalence of five arboviruses in Zebu cattle in the Central African Republic. Trans R Soc Trop Med Hyg (1996) 0.96

[Inactivation of poliomyelitis virus by ultraviolet rays using a series apparatus. Comparison with bacteriologic results]. Bull Acad Natl Med (1968) 0.96

Spiral computed tomography-intravenous cholangiography with three-dimensional reconstructions for imaging the biliary tree. Australas Radiol (2006) 0.95

In vitro formation of polyglutamyl derivatives of methotrexate and 7-hydroxymethotrexate in human lymphoblastic leukemia cells. Cancer Res (1983) 0.94

Kinetics of uptake and intracellular binding of Cyclosporine A in RAJI cells, in vitro. Biochem Pharmacol (1986) 0.94

Segregation of QTL for production traits in commercial meat-type chickens. Genet Res (2004) 0.94

Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin. Antimicrob Agents Chemother (1997) 0.94

No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy. Results from a randomized clinical trial of 303 patients. The "Petites Cellules" Group. Cancer (1993) 0.93

Properties of malate dehydrogenase isolated from Methanospirillum hungatii. Can J Microbiol (1979) 0.93

Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. Drug Metab Dispos (1991) 0.93

GDEP, a new gene differentially expressed in normal prostate and prostate cancer. Prostate (2001) 0.92

Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin. J Pharm Sci (1989) 0.92

Naproxen kinetics in synovial fluid of patients with osteoarthritis. Br J Clin Pharmacol (1988) 0.92

Oral bioavailability of trovafloxacin with and without food in healthy volunteers. J Antimicrob Chemother (1997) 0.92

The incidence of tinea versicolor in central Sweden. J Med Microbiol (1983) 0.92

The effect of acidic polysaccharides and prostaglandin-like substances isolated from Propionibacterium acnes on granulocyte chemotaxis. Experientia (1979) 0.92

Quantitative trait locus detection in commercial broiler lines using candidate regions. J Anim Sci (2003) 0.91

Antitumor active beta-D-glucans from Phytophthora parasitica. Carbohydr Res (1988) 0.91

Chemical composition of antigen 60 from Mycobacterium bovis BCG. Scand J Immunol (1986) 0.90

Association of HPA axis genes with suicidal behaviour in schizophrenia. J Psychopharmacol (2008) 0.90

Amiodarone and digoxin for refractory fetal tachycardia. Am J Cardiol (1987) 0.90

Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit. Br J Pharmacol (1985) 0.89

Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry (1999) 0.89

Activation volume and energetic properties of the binding of CO to hemoproteins. Biophys J (1994) 0.89

Combination of thymidine phosphorylase gene transfer and deoxyinosine treatment greatly enhances 5-fluorouracil antitumor activity in vitro and in vivo. Mol Cancer Ther (2001) 0.89

Clinical pharmacokinetics of ciclosporin A in bone marrow transplantation patients. Cancer Chemother Pharmacol (1985) 0.88

Trimazosin: relationships between hypotensive effect, vascular responsiveness, and drug and metabolite concentrations. J Cardiovasc Pharmacol (1985) 0.88

Relationship between plasma prazosin concentration and alpha-antagonism in humans: comparison of conventional and rate-controlled (Oros) formulations. Clin Pharmacol Ther (1988) 0.88

Some effects of visible light on Escherichia coli. J Bacteriol (1974) 0.88

Characterization of midazolam metabolism using human hepatic microsomal fractions and hepatocytes in suspension obtained by perfusing whole human livers. Biochem Pharmacol (1988) 0.87

QTL analysis of body weight and conformation score in commercial broiler chickens using variance component and half-sib analyses. Anim Genet (2006) 0.87

The expression of peripheral benzodiazepine receptors in human skin: the relationship with epidermal cell differentiation. Br J Dermatol (1999) 0.87

Mitotic responsiveness of cultured adult human hepatocytes to epidermal growth factor, transforming growth factor alpha, and human serum. Gastroenterology (1992) 0.87

Effects of thyroid hormone on synaptogenesis in the molecular layer of the developing rat cerebellum. J Physiol (Paris) (1984) 0.86

Excretion and metabolism of trovafloxacin in humans. Drug Metab Dispos (1997) 0.86

Metabolism of digoxin, digoxigenin digitoxosides and digoxigenin in human hepatocytes and liver microsomes. Fundam Clin Pharmacol (1991) 0.86

Amiodarone and desethylamiodarone elimination kinetics following withdrawal of long-term amiodarone maintenance therapy. Biopharm Drug Dispos (1985) 0.86

Assessing pre-procedural subgingival irrigation and rinsing with an antiseptic mouthrinse to reduce bacteremia. J Am Dent Assoc (1996) 0.85

Obesity, type 2 diabetes and risk of digestive cancer. Gastroenterol Clin Biol (2010) 0.85

Clinical pharmacological studies with doxazosin. Br J Clin Pharmacol (1986) 0.85

Antibodies against extractable components from Propionibacterium acnes in humans with and without acne vulgaris. Arch Dermatol Res (1980) 0.85

In vivo and in vitro pharmacokinetics and metabolism of vincaalkaloids in rat. II. Vinblastine and vincristine. Eur J Drug Metab Pharmacokinet (1991) 0.85

The use of speech therapy in the treatment of globus pharyngeus patients. A randomised controlled trial. Rev Laryngol Otol Rhinol (Bord) (2003) 0.85

Novel approach to transvenous pacemaker implantation in a post-fontan adolescent. Pediatr Cardiol (1997) 0.85

Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine). Cancer Res (1987) 0.84

Involvement of the macrolide antibiotic inducible cytochrome P-450 LM3c in the metabolism of midazolam by microsomal fractions prepared from rabbit liver. Biochem Pharmacol (1988) 0.84

Plasma concentrations and pharmacokinetics of midazolam during anaesthesia. J Pharm Pharmacol (1986) 0.84

Stiripentol: efficacy and tolerability in children with epilepsy. Epilepsia (1999) 0.84

The pharmacokinetics of doxazosin in elderly normotensives. Br J Clin Pharmacol (1986) 0.84

Steady-state dosage regimen calculations in linear pharmacokinetics. Int J Biomed Comput (1986) 0.84

Cicletanide improves outcome after left circumflex coronary artery occlusion-reperfusion in the dog. J Cardiovasc Pharmacol (1986) 0.84

Pharmacokinetics and metabolism of Navelbine. Semin Oncol (1989) 0.84

Débriding properties of krill enzymes in necrotic leg ulcers. Arch Dermatol (1989) 0.84

[Study of a new pentavalent vaccine combination]. Ann Microbiol (Paris) (1973) 0.84

7-Hydroxymethotrexate cytotoxicity and selectivity in a human Burkitt's lymphoma cell line versus human granulocytic progenitor cells: rescue by folinic acid and nucleosides. Eur J Cancer Clin Oncol (1986) 0.84

Pharmacokinetics of [18F]trovafloxacin in healthy human subjects studied with positron emission tomography. Antimicrob Agents Chemother (1998) 0.84

Synthesis and properties of 7-hydroxymethotrexate polyglutamyl derivatives in Ehrlich ascites tumor cells in vitro. J Biol Chem (1984) 0.83

Molsidomine prevents post-ischaemic ventricular fibrillation in dogs. Br J Pharmacol (1986) 0.83